Neurological Surgery Doctors in Lawrenceville, GA Accepting Medicare

6 Neurological Surgery doctors found. Showing 1 - 6

Dr. Don William Penney, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 753 Old Norcross Rd, Ste A, Lawrenceville, GA 30046 Phone: 770-995-5333    Fax: 770-682-5322

Michael A Amaral, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 575 Professional Drive, Suite 350, Lawrenceville, GA 30046 Phone: 678-312-2700    Fax: 678-312-2730

Christopher Banerjee, MD, MPH Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2200 Medical Center Blvd Ste 250, Lawrenceville, GA 30046 Phone: 678-312-2700    Fax: 678-312-2730

Dr. Michael Thomas Stechison, MD PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 575 Professional Drive, Suite 350, Lawrenceville, GA 30046 Phone: 678-312-2700    Fax: 678-312-2730

Dr. Robert Emerson Ayer, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 575 Professional Dr, Suite 350, Lawrenceville, GA 30046 Phone: 678-312-2700    Fax: 678-312-2730

Dr. Princewill U Ehirim, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Center Blvd, Suite 200, Lawrenceville, GA 30045 Phone: 678-916-7053    Fax: 678-826-0867

News Archive

ADVENTRX seeks meeting with FDA to discuss ANX-514 docetaxel emulsion study findings

ADVENTRX Pharmaceuticals, Inc. today announced it has submitted a request to the U.S. Food and Drug Administration (FDA) to schedule a meeting for the purpose of discussing its product candidate ANX-514 (docetaxel emulsion for injection). The FDA is expected to set the meeting date within 60 days of receiving the request from ADVENTRX.

Medicaid news: Kansas insurer says 'no' to Medicaid

The state of Kansas' largest insurance company has decided it doesn't want to participate in Gov. Sam Brownback's plan to move Medicaid patients into privatized managed-care programs. In a letter addressed "Dear provider," Angie Strecker, director of institutional relations for Blue Cross Blue Shield of Kansas, said the insurer "has decided not to submit a proposal to the state to be a Medicaid contractor."

Cycling JAK inhibitors can be effective for treating people with difficult-to-treat rheumatoid arthritis

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor (JAK inhibitor) can achieve success either cycling to other JAKi medications or switching to a biologic drug.

Gene mutation may increase the risk of prostate cancer up to three times in African-American

Researchers have identified a gene mutation that may increase the risk of prostate cancer up to three times in African-American men with a family history of the disease.

Read more Medical News

› Verified 2 days ago